Matches in SemOpenAlex for { <https://semopenalex.org/work/W2336547219> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2336547219 abstract "Background: Besides inflation, the recent expansion of health insurance coverage and the limited regulation of drug pricing in the US has caused per capita pharmaceutical expenditures to increase substantially. We aim to examine the proportion of health care spending used on drugs and its association with burden of comorbidity among adults with cardiovascular disease (CVD). Methods: Using the 2012 Medical Expenditures Panel Survey (MEPS), adults aged 40 years with an ICD-9 diagnosis of CVD (410, 413, 414, 428, 433, 434, 435, 436, 437, 427, 440, 443, or 447) (n=1,846) from the medical condition file were studied. The burden of comorbidity was estimated using the Charlson Comorbidity Index (CCI). We used the two-part econometric model to estimate the mean healthcare and pharmaceutical expenditures and it association with CCI. The mean proportion of health care spending for pharmaceuticals was estimated and tested for trend across CCI using the variance-weighted least squares. All analyses took into account the study’s complex survey design and were weighted to the U.S. population. Results: Approximately 18.9 million adults aged 40 years (mean age[SD]: 69[15] years; 44% females) had a diagnosis of CVD; 37% had CCI=1, 26% had CCI=2. Overall, healthcare expenditures among adults with CVD was $248.4 billion; 26.1% ($64.8 billion) of which was spent on pharmaceuticals. Both absolute total health care expenditures and pharmaceutical expenditures significantly increased proportionally with CCI (table). However, pharmaceutical expenditures expressed as proportion of total health care spending did not increase with greater co-morbid disease burden (p-trend =0.198). Conclusion: Pharmaceutical expenditure is a significant contributor of healthcare spending (>1 in every 3 US dollars spent) among adults with established CVD. It is imperative to critically assess interplay of such issues as pricing and appropriate utilization of pharmaceutical agents to mitigate increasing healthcare spending among those with CVD." @default.
- W2336547219 created "2016-06-24" @default.
- W2336547219 creator A5001990853 @default.
- W2336547219 creator A5003912464 @default.
- W2336547219 creator A5006842773 @default.
- W2336547219 creator A5008531984 @default.
- W2336547219 creator A5009869766 @default.
- W2336547219 creator A5010041931 @default.
- W2336547219 creator A5016093592 @default.
- W2336547219 creator A5016261061 @default.
- W2336547219 creator A5027077715 @default.
- W2336547219 creator A5054739374 @default.
- W2336547219 creator A5056552067 @default.
- W2336547219 creator A5064612687 @default.
- W2336547219 creator A5068957393 @default.
- W2336547219 creator A5075729329 @default.
- W2336547219 creator A5083713079 @default.
- W2336547219 creator A5089569098 @default.
- W2336547219 date "2016-03-01" @default.
- W2336547219 modified "2023-09-22" @default.
- W2336547219 title "Abstract 230: Per Capita Proportion of Total Health Care Expenditures on Pharmaceuticals Among US Adults With Cardiovascular Disease: 2012 Medical Expenditure Panel Survey" @default.
- W2336547219 doi "https://doi.org/10.1161/circoutcomes.9.suppl_2.230" @default.
- W2336547219 hasPublicationYear "2016" @default.
- W2336547219 type Work @default.
- W2336547219 sameAs 2336547219 @default.
- W2336547219 citedByCount "0" @default.
- W2336547219 crossrefType "journal-article" @default.
- W2336547219 hasAuthorship W2336547219A5001990853 @default.
- W2336547219 hasAuthorship W2336547219A5003912464 @default.
- W2336547219 hasAuthorship W2336547219A5006842773 @default.
- W2336547219 hasAuthorship W2336547219A5008531984 @default.
- W2336547219 hasAuthorship W2336547219A5009869766 @default.
- W2336547219 hasAuthorship W2336547219A5010041931 @default.
- W2336547219 hasAuthorship W2336547219A5016093592 @default.
- W2336547219 hasAuthorship W2336547219A5016261061 @default.
- W2336547219 hasAuthorship W2336547219A5027077715 @default.
- W2336547219 hasAuthorship W2336547219A5054739374 @default.
- W2336547219 hasAuthorship W2336547219A5056552067 @default.
- W2336547219 hasAuthorship W2336547219A5064612687 @default.
- W2336547219 hasAuthorship W2336547219A5068957393 @default.
- W2336547219 hasAuthorship W2336547219A5075729329 @default.
- W2336547219 hasAuthorship W2336547219A5083713079 @default.
- W2336547219 hasAuthorship W2336547219A5089569098 @default.
- W2336547219 hasConcept C126322002 @default.
- W2336547219 hasConcept C127598652 @default.
- W2336547219 hasConcept C144024400 @default.
- W2336547219 hasConcept C149923435 @default.
- W2336547219 hasConcept C160735492 @default.
- W2336547219 hasConcept C162324750 @default.
- W2336547219 hasConcept C2779159551 @default.
- W2336547219 hasConcept C2780128664 @default.
- W2336547219 hasConcept C2780777579 @default.
- W2336547219 hasConcept C2908647359 @default.
- W2336547219 hasConcept C2983635472 @default.
- W2336547219 hasConcept C50522688 @default.
- W2336547219 hasConcept C71924100 @default.
- W2336547219 hasConcept C74909509 @default.
- W2336547219 hasConcept C99454951 @default.
- W2336547219 hasConceptScore W2336547219C126322002 @default.
- W2336547219 hasConceptScore W2336547219C127598652 @default.
- W2336547219 hasConceptScore W2336547219C144024400 @default.
- W2336547219 hasConceptScore W2336547219C149923435 @default.
- W2336547219 hasConceptScore W2336547219C160735492 @default.
- W2336547219 hasConceptScore W2336547219C162324750 @default.
- W2336547219 hasConceptScore W2336547219C2779159551 @default.
- W2336547219 hasConceptScore W2336547219C2780128664 @default.
- W2336547219 hasConceptScore W2336547219C2780777579 @default.
- W2336547219 hasConceptScore W2336547219C2908647359 @default.
- W2336547219 hasConceptScore W2336547219C2983635472 @default.
- W2336547219 hasConceptScore W2336547219C50522688 @default.
- W2336547219 hasConceptScore W2336547219C71924100 @default.
- W2336547219 hasConceptScore W2336547219C74909509 @default.
- W2336547219 hasConceptScore W2336547219C99454951 @default.
- W2336547219 hasIssue "suppl_2" @default.
- W2336547219 hasLocation W23365472191 @default.
- W2336547219 hasOpenAccess W2336547219 @default.
- W2336547219 hasPrimaryLocation W23365472191 @default.
- W2336547219 hasRelatedWork W140583757 @default.
- W2336547219 hasRelatedWork W1577500205 @default.
- W2336547219 hasRelatedWork W2016941404 @default.
- W2336547219 hasRelatedWork W2033321697 @default.
- W2336547219 hasRelatedWork W2064837641 @default.
- W2336547219 hasRelatedWork W2107843858 @default.
- W2336547219 hasRelatedWork W2523495956 @default.
- W2336547219 hasRelatedWork W2619166858 @default.
- W2336547219 hasRelatedWork W3026001727 @default.
- W2336547219 hasRelatedWork W3034245077 @default.
- W2336547219 hasVolume "9" @default.
- W2336547219 isParatext "false" @default.
- W2336547219 isRetracted "false" @default.
- W2336547219 magId "2336547219" @default.
- W2336547219 workType "article" @default.